ResMed Inc

Healthcare · Medical Instruments & Supplies

222.00$ -0.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

ResMed Inc (RMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 8,966 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RMD
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Total Assets	55	65	90	116	288	376	460	549	774	1,007	1,252	1,406	1,508	1,626	2,069	2,138	2,211	2,361	2,184	3,259	3,468	3,064	4,108	4,587	4,728	5,096	6,752	6,872	8,174	8,966
Current Assets	44	47	51	69	178	194	242	283	360	510	669	739	853	985	1,292	1,361	1,449	1,556	1,444	1,420	1,644	1,066	1,145	1,523	1,575	1,931	2,368	2,358	3,506	4,325
Cash	9.1	16	11	18	40	73	114	129	142	220	258	321	416	489	735	810	876	906	717	731	822	189	147	463	295	274	228	238	1,209	1,469
Cash & Short-Term Investments	9.1	16	17	22	103	93	121	141	142	220	278	321	416	489	735	810	876	906	717	731	822	189	147	463	295	274	228	238	1,209	1,469
Receivables	7.8	13	18	25	32	46	57	67	104	138	176	209	214	232	284	285	327	360	363	382	451	484	528	475	625	576	705	837	991	1,036
Inventory	5.8	7.6	11	16	30	41	49	56	89	116	157	158	157	186	201	174	146	165	247	224	268	269	350	417	457	744	998	822	928	946
Property, Plant & Equipment	–	–	–	37	55	79	105	147	174	245	311	357	378	387	462	434	411	434	388	384	394	387	387	536	592	630	666	699	718	–
Goodwill	–	–	–	5.6	48	93	102	106	181	196	207	235	213	199	235	256	275	289	264	1,059	1,065	1,069	1,856	1,890	1,928	1,936	2,770	2,842	3,047	3,362
Intangible Assets	4.8	5.9	7.3	7.0	49	95	106	111	230	49	47	47	35	31	48	55	50	45	47	300	262	215	522	448	393	346	552	486	465	453
Total Liabilities	10	14	18	22	188	183	173	188	300	269	321	324	393	339	338	530	600	603	597	1,564	1,508	1,005	2,035	2,090	1,842	1,735	2,622	2,008	2,207	2,381
Current Liabilities	10	14	18	22	34	49	51	61	219	129	202	193	269	313	209	253	574	270	267	639	360	511	556	603	912	689	759	911	1,019	1,395
Short-Term Debt	0.3	0.2	–	–	–	–	19	23	115	4.9	28	44	68	122	0.2	0.1	300	0.0	148	300	215	11	12	33	36	32	32	35	40	289
Accounts Payable	2.6	3.8	4.8	5.9	8.0	12	19	19	34	45	53	56	48	58	55	55	61	85	81	93	93	93	116	136	138	159	151	238	278	309
Long-Term Debt	–	–	–	–	150	123	113	113	59	116	88	94	94	–	100	251	0.8	301	301	875	1,079	270	1,259	1,164	643	765	1,431	697	658	399
Shareholders' Equity	45	51	72	94	100	193	286	361	474	738	931	1,082	1,115	1,288	1,731	1,608	1,611	1,758	1,587	1,695	1,960	2,059	2,072	2,497	2,886	3,361	4,130	4,864	5,968	6,585
Retained Earnings	17	27	43	66	77	115	160	218	282	371	437	548	695	885	1,112	1,367	1,577	1,780	1,976	2,160	2,316	2,432	2,436	2,833	3,080	3,614	4,253	4,992	6,081	7,255
Shares Outstanding	117	120	124	129	134	136	138	141	150	154	157	157	154	155	157	149	146	144	143	142	142	144	144	146	146	147	147	148	147	145

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings